Dr. DeKosky developed new technologies for sequencing complete antibody variable regions from single B cells during his Ph.D. in the lab of George Georgiou at the University of Texas at Austin. As a postdoc with John Mascola at the NIAID Vaccine Research Center, Dr. DeKosky applied high-throughput antibody sequencing and functional repertoire characterization to accelerate public health vaccine development. The DeKosky lab at KU leverages high-throughput platforms to understand the critical features of adaptive immune protection and to develop novel strategies to combat human diseases. 